ACCOUNTING & FINANCE

FINANCIAL STATEMENT
RATIO ANALYSIS

Diva Tertia Almira (470320)

 HISTORY
Company Profile Founded on September 10, 1966 by 6 siblings. Kalbe Farma
first began operations in a house garage that was owned by
the founders.

PRODUCTS
The Kalbe Group has brands in the prescription drugs, OTC
drugs, energy drink and nutrition products, distribution arm
that reaches over 1 million outlets. Company brands in
healthcare and pharmaceutical segments include Promag,
Mixagrip, Woods, Komix, Prenagen and Extra Joss.

DIVISIONS
The Prescription Pharmaceutical Division (23%)
Consumer Health Division (17%)
Nutritional Division (30%)
Distribution and Logistics Division (30%)

Source: Kalbe.co.id
Financial Ratio
Notes
Industry Average using: Kimia Farma,
Phapros, Pyridam, Farma, Indofarma &
Darya Varia performance
Strength & Weakness
STRENGTH
All of Kalbe Farma financial ratios are above the
industry average, this shows that it's the Market
Leader and other company should use Kalbe Farma as a
benchmark
Kalbe Farma Debt Ratio is way below Industry
average, to finance it's assets Kalbe mostly use Equity.
This shows that the company is healthy and less risky
than others
Kalbe Farma is very profitable compared to it's
competitor, scoring almost twice as much on all of
profitability ratio
WEAKNESS
Most of Kalbe Farma ratios are declining in 2019 but
there are few ratios that declining even before 2019
Fixed Assets turnover which indicates the effectiveness
of firm's ability to use it's assets keep declining from
2017 to 2019
All of Kalbe Farma's Profitability Ratios are declining
from 2017 and decline even further in 2019, even
though it's much higher than it's competition
Though market/book ratio of Kalbe Farma is higher
compared to it's competition, the ratios keep declining